These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9190537)

  • 1. [Molecular-genetic aspects of neurofibromatosis].
    Hulsebos TJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):620-3. PubMed ID: 9190537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.
    Rouleau GA; Merel P; Lutchman M; Sanson M; Zucman J; Marineau C; Hoang-Xuan K; Demczuk S; Desmaze C; Plougastel B
    Nature; 1993 Jun; 363(6429):515-21. PubMed ID: 8379998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
    Kley N; Seizinger BR
    Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.
    Andersen LB; Fountain JW; Gutmann DH; Tarlé SA; Glover TW; Dracopoli NC; Housman DE; Collins FS
    Nat Genet; 1993 Feb; 3(2):118-21. PubMed ID: 8499944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 gene mutations in neuroblastoma.
    The I; Murthy AE; Hannigan GE; Jacoby LB; Menon AG; Gusella JF; Bernards A
    Nat Genet; 1993 Jan; 3(1):62-6. PubMed ID: 8490657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis and associated tumour suppressor genes.
    Zwarthoff EC
    Pathol Res Pract; 1996 Jul; 192(7):647-57. PubMed ID: 8880865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
    Bianchi AB; Hara T; Ramesh V; Gao J; Klein-Szanto AJ; Morin F; Menon AG; Trofatter JA; Gusella JF; Seizinger BR
    Nat Genet; 1994 Feb; 6(2):185-92. PubMed ID: 8162073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis. Nosological considerations.
    Badiu C; Stefanache F
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):39-44. PubMed ID: 12089989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the neurofibromatoses.
    Gutmann DH
    Curr Opin Neurol; 1994 Apr; 7(2):166-71. PubMed ID: 8019663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor gene regulation of cell growth: recent insights into neurofibromatosis 1 and 2 gene function.
    Uhlmann EJ; Gutmann DH
    Cell Biochem Biophys; 2001; 34(1):61-78. PubMed ID: 11394441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic and molecular pathogenesis of NF1 and NF2.
    Yohay KH
    Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.
    Legius E; Marchuk DA; Collins FS; Glover TW
    Nat Genet; 1993 Feb; 3(2):122-6. PubMed ID: 8499945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.
    Jacks T; Shih TS; Schmitt EM; Bronson RT; Bernards A; Weinberg RA
    Nat Genet; 1994 Jul; 7(3):353-61. PubMed ID: 7920653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.
    Lutchman M; Rouleau GA
    Cancer Res; 1995 Jun; 55(11):2270-4. PubMed ID: 7757975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
    Scoles DR; Huynh DP; Morcos PA; Coulsell ER; Robinson NG; Tamanoi F; Pulst SM
    Nat Genet; 1998 Apr; 18(4):354-9. PubMed ID: 9537418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor genes as negative growth regulators in development and differentiation.
    Gutmann DH
    Int J Dev Biol; 1995 Dec; 39(6):895-908. PubMed ID: 8901192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation.
    Cheng JQ; Lee WC; Klein MA; Cheng GZ; Jhanwar SC; Testa JR
    Genes Chromosomes Cancer; 1999 Mar; 24(3):238-42. PubMed ID: 10451704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.